The objective of this study was to assess the effect on health-related quality of life of acupuncture and sham acupuncture as adjunctive treatment in intractable epilepsy. We performed a randomized controlled trail with two parallel treatment arms at The National Center for Epilepsy in Norway, a comprehensive epilepsy center. Thirty-four patients with long-standing drug resistant epilepsy completed the study. The intervention consisted of 20 acupuncture treatments (bilateral needling of three acupoints plus one or two individually chosen points) or sham acupuncture (bilateral needling with smaller needles of three points outside the traditional meridians) over 8 weeks. The main outcome measures were changes in mean health-related quality of life scores for the two groups after 8 weeks, using the 89-item Quality of Life in Epilepsy (QOLIE-89) questionnaire. We found no difference between the acupuncture and sham acupuncture groups in score changes in any dimension of the QOLIE-89 questionnaire, despite testing a large number of dimensions. We also found no change in QOLIE-89 scores between baseline and 8 weeks in either groups. In conclusion, we could not demonstrate a significant effect of traditional acupuncture or sham acupuncture on the health-related quality of life of patients with intractable epilepsy.
INTRODUCTION
In traditional Chinese medicine acupuncture has been used to treat a number of different diseases, including epilepsy 1, 2 . Acupuncture has been used against experimental epilepsies in animals 3, 4 , and auricular acupuncture has been used for intractable idiopathic epilepsy in dogs 5 . From work on animal models it has been suggested that the mechanism of acupuncture in suppressing epileptic seizures is through the release of neurotransmittors, such as endogenous opioid peptides, serotonin and gamma-butyric acid 6 . However, it remains unclear whether this would be specific to certain types of epilepsy.
In humans the efficacy of scalp needling 7 , electroacupuncture 8 and catgut embedding in acupoints in treating epilepsy is reported 9 , and successful treatment of status epilepticus with acupuncture is reported in eight cases 10 . Recently some of our patients with epilepsy travelled to China on their own for acupuncture treatment, and some reported good results.
Thus, both theoretical and practical considerations suggested the possibility of a beneficial effect of acupuncture in epilepsy. However, we could not find documented controlled trials of the efficacy of acupuncture in treating epilepsy. We have recently reported a lack of beneficial effect of acupuncture on seizure frequency and EEG findings 11 . The present study is an extension of this study, assessing the impact of acupuncture on the health-related quality of life (HRQL) in patients with intractable epilepsy.
METHODS

Patients
Patients were recruited from the outpatient population of The National Center for Epilepsy, Norway, all of them suffering from chronic intractable epilepsy. Inclusion criteria were age ≥18 years, duration of epilepsy >2 years, partial or generalized epilepsy and one or more seizure per week. Exclusion criteria were non-epileptic seizures alone or in combination with epilepsy, progressive cerebral illness or inability to cooperate in the study.
Forty-one patients were eligible for the study. Seven patients withdrew during the baseline period, but before randomization, because they found participation inconvenient. Thirty-four patients were included in the study and randomized to the two treatment groups. Eighteen patients received acupuncture treatment, while 16 received sham acupuncture. During the study, one patient in each group was hospitalized and had changes in their medication. No patients dropped out after randomization.
At baseline the two treatment groups were comparable with regard to age, gender, duration of epilepsy, age at onset of epilepsy, seizure frequency and proportion of patients who previously had had acupuncture (Table 1) .
Study design
The study included a baseline period of 10 weeks, a treatment period of 8 weeks and follow-up for the quality of life data after another 4 weeks. After the baseline period, the patients were randomized to acupuncture or sham acupuncture through a restricted randomization procedure, using block randomization with blocks of four patients 12 .
All patients were treated on an outpatient basis and received 20 treatments (three treatments per week for 3.5 weeks, 1 week pause and another series of treatments over 3.5 weeks). Each treatment lasted about 30 minutes.
Both acupuncture and sham acupuncture treatments were administered by two experienced acupuncturists, both being staff members of the Shanghai University of Traditional Chinese Medicine. Each patient was treated by the same acupuncturist throughout the study.
To control factors which could affect the outcome, current antiepileptic and co-medication were held stable and monitored during baseline and follow-up. Both patients and epileptologists were blinded. The study was approved by the Regional Ethics Review Committee. Informed consent was obtained after both verbal and written information.
Acupuncture technique
The acupuncture treatment given was administered according to the method used at the Shanghai University of Traditional Chinese Medicine. All patients were diagnosed according to the principles of traditional Chinese medicine. One of five main diagnoses was given to each patient, and they were all treated by bilateral needling of the acupoints LR3, LI4 and GV20 13 , in addition to one or two points based on individual diagnosis. The needles used were traditional Chinese acupuncture needles, diameter 0.3 mm and length 25-55 mm (1-2 cun, most often 1.5 cun; cun is an individual system of measurement used in traditional Chinese medicine, familiar to acupuncturists around the world) and placed at variable depths. The needles were rotated or stimulated manually in order to obtain the needling sensation (Te chi). As part of this individualized treatment the patients could have scalpneedling or electroacupuncture using a standard transcutaneous nerve stimulation apparatus with acupuncture needles as electrodes. For electroacupuncture we used an Elpha 2000 instrument (Biometer International As, DK-5210 Odense, Denmark) at 3 Hz and 3-20 mA.
Sham acupuncture technique
Sham acupuncture was given as bilateral needling of three sham acupoints chosen by a group of Chinese and Norwegian acupuncturists: S1 (sham1)-2.5 cun to the side of the umbilicus, S2-3 cun above the midpoint of the patella, S3-1 cun below the midpoint between LI15 and TE14 13 . In the sham group we used thinner needles (0.25 mm diameter and 0.5 cun length), which were placed at a depth of 0.3 cun, and were stimulated neither manually nor with electric current.
Assessment of health-related quality of life HRQL was evaluated with a Norwegian translation of the 89-item Quality of Life in Epilepsy questionnaire (QOLIE-89) 14, 15 , administered at baseline and after 8 weeks of treatment. The QOLIE-89 questionnaire consists of a generic core, the RAND 36-item Health Survey 1.0, also known as the Short Form 36 (SF-36) 16, 17 , and a collection of items believed to be more specific and relevant for epilepsy 14, 15 . The QOLIE-89 questionnaire assesses HRQL during the last 4 weeks. It has 17 different multi-item scales, which in addition are aggregated into an overall score. Reliability and validity of the Norwegian version of the QOLIE-89 has previously been reported 18 .
Statistical analysis
Statistical analyses were carried out under the principle of intention to treat. For comparison of baseline The effect of acupuncture treatment was assessed as the difference in HRQL scores, using the QOLIE-89 instrument, between questionnaires filled in at baseline and after 8 weeks of treatment. We compared the mean difference in score changes from baseline to 8 weeks for the two groups using a t-test for independent samples. Additionally, score changes for the QOLIE-89 dimensions were assessed for the acupuncture group and sham acupuncture group separately, using a one sample t-test. We chose a 5% significance level.
In this study we included 34 patients, which gives the study a power of 80% to detect a mean difference between groups of 1 SD on the HRQL scales.
RESULTS
At baseline there was no significant difference between the sham group and the acupuncture group in any of the QOLIE-89 dimensions (Table 2) . Baseline QOLIE-89 scores were transformed to be comparable with an American reference population of mild to moderate epilepsy patients, with a mean score of 50 and standard deviation of 10 14, 15 . The patients in our study had slightly lower mean scores than this American reference population (Table 2) . Between baseline and the end of the intervention period of 8 weeks, there was no significant difference in score changes between the two intervention groups on any of the QOLIE-89 scales (Table 3) . When analyzing the two groups separately, there were no significant changes from baseline to 8 weeks in any QOLIE-89 dimension in either the sham acupuncture or the acupuncture group.
DISCUSSION
In this study of adjunctive treatment with acupuncture or sham acupuncture, we found no significant difference in HRQL score changes between the two intervention groups over the course of an 8 week treatment period, and we could not detect a change from baseline in either group. This is in agreement with the seizure frequency data previously published from this study 11 .
We are not aware of other controlled studies of acupuncture treatment of epilepsy similar to our study. Other studies of acupuncture report a similar needle placement as used in our study, also using LR3, LI4 and GV20 among the acupoints 10 and a similar technique of electrostimulation 8 . In clinical practice in China there seems to be a tendency to choose points on the Governor vessel and scalp, preferably with electrical stimulation 1 .
Choice of placebo or intervention for the control group in trials of acupuncture is controversial. In 28 controlled studies, 28 different acupuncture placebos were used 19 , making comparisons between studies difficult. In this study we chose to use needling as treatment of the control group, using a minimalist approach: piercing the skin outside the usual acupuncture points, using fine needles without any stimulation, and not obtaining the needling sensation.
There are several limitations to our study. One limitation is the small sample size, which only would enable us to detect differences of 1 SD, which normally is a very large difference. With a larger sample size we might have detected smaller differences at the chosen power level.
There were variations in the treatments given and the acupoints used within the groups; however, this heterogeneity is a part of traditional Chinese acupuncture. Our patients had chronic and drug resistant epilepsies, they were heterogeneous with regard to seizure type and frequency and they clearly are not representative for the total population of patients with epilepsy.
Several aspects of the QOLIE-89 questionnaire have not yet been tested. Tests of longitudinal change or responsiveness of this measure are lacking, as for many other instruments for assessing HRQL. Despite the many limitations of such instruments, we think measures of functional status and well-being are important measures of clinical trial outcomes in chronic diseases.
In conclusion, in this trial we were not able to detect significant changes in HRQL either with the acupuncture treatment or with the sham acupuncture.
